141 related articles for article (PubMed ID: 12918070)
1. Human papillomavirus type 16 E6 variants and HLA class II alleles among Japanese women with cervical cancer.
Matsumoto K; Yasugi T; Nakagawa S; Okubo M; Hirata R; Maeda H; Yoshikawa H; Taketani Y
Int J Cancer; 2003 Oct; 106(6):919-22. PubMed ID: 12918070
[TBL] [Abstract][Full Text] [Related]
2. Enhanced oncogenicity of human papillomavirus type 16 (HPV16) variants in Japanese population.
Matsumoto K; Yoshikawa H; Nakagawa S; Tang X; Yasugi T; Kawana K; Sekiya S; Hirai Y; Kukimoto I; Kanda T; Taketani Y
Cancer Lett; 2000 Aug; 156(2):159-65. PubMed ID: 10880765
[TBL] [Abstract][Full Text] [Related]
3. HPV 16 infection and progression of cervical intra-epithelial neoplasia: analysis of HLA polymorphism and HPV 16 E6 sequence variants.
Bontkes HJ; van Duin M; de Gruijl TD; Duggan-Keen MF; Walboomers JM; Stukart MJ; Verheijen RH; Helmerhorst TJ; Meijer CJ; Scheper RJ; Stevens FR; Dyer PA; Sinnott P; Stern PL
Int J Cancer; 1998 Oct; 78(2):166-71. PubMed ID: 9754647
[TBL] [Abstract][Full Text] [Related]
4. Uneven distribution of HPV 16 E6 prototype and variant (L83V) oncoprotein in cervical neoplastic lesions.
Andersson S; Alemi M; Rylander E; Strand A; Larsson B; Sällström J; Wilander E
Br J Cancer; 2000 Aug; 83(3):307-10. PubMed ID: 10917543
[TBL] [Abstract][Full Text] [Related]
5. HPV16 E6 variants and HLA class II polymorphism among Chinese women with cervical cancer.
Wu Y; Liu B; Lin W; Xu Y; Li L; Zhang Y; Chen S; Xu A
J Med Virol; 2007 Apr; 79(4):439-46. PubMed ID: 17311339
[TBL] [Abstract][Full Text] [Related]
6. Association between human papillomavirus 16 E6 variants and human leukocyte antigen class I polymorphism in cervical cancer of Swedish women.
Zehbe I; Mytilineos J; Wikström I; Henriksen R; Edler L; Tommasino M
Hum Immunol; 2003 May; 64(5):538-42. PubMed ID: 12691704
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus type 16 E6 variants in cervical carcinoma: relationship to host genetic factors and clinical parameters.
Brady CS; Duggan-Keen MF; Davidson JA; Varley JM; Stern PL
J Gen Virol; 1999 Dec; 80 ( Pt 12)():3233-3240. PubMed ID: 10567656
[TBL] [Abstract][Full Text] [Related]
8. Human Papillomavirus (HPV) 16/18 E6 Oncoprotein Expression in Infections with Single and Multiple Genotypes.
Wu Z; Li TY; Jiang M; Yu L; Zhao J; Wang H; Zhang X; Chen W; Qiao Y
Cancer Prev Res (Phila); 2019 Feb; 12(2):95-102. PubMed ID: 30606718
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus 16 E6 polymorphisms in cervical lesions from different European populations and their correlation with human leukocyte antigen class II haplotypes.
Zehbe I; Tachezy R; Mytilineos J; Voglino G; Mikyskova I; Delius H; Marongiu A; Gissmann L; Wilander E; Tommasino M
Int J Cancer; 2001 Dec; 94(5):711-6. PubMed ID: 11745467
[TBL] [Abstract][Full Text] [Related]
10. Uniform distribution of HPV 16 E6 and E7 variants in patients with normal histology, cervical intra-epithelial neoplasia and cervical cancer.
Nindl I; Rindfleisch K; Lotz B; Schneider A; Dürst M
Int J Cancer; 1999 Jul; 82(2):203-7. PubMed ID: 10389753
[TBL] [Abstract][Full Text] [Related]
11. Co-mutation of HPV16 E6 and E7 genes in Thai squamous cervical carcinomas.
Vaeteewoottacharn K; Jearanaikoon P; Ponglikitmongkol M
Anticancer Res; 2003; 23(2C):1927-31. PubMed ID: 12820481
[TBL] [Abstract][Full Text] [Related]
12. Analysis of human papillomavirus type 16 E6 variants in relation to p53 codon 72 polymorphism genotypes in cervical carcinogenesis.
van Duin M; Snijders PJ; Vossen MT; Klaassen E; Voorhorst F; Verheijen RH; Helmerhorst TJ; Meijer CJ; Walboomers JM
J Gen Virol; 2000 Feb; 81(Pt 2):317-25. PubMed ID: 10644829
[TBL] [Abstract][Full Text] [Related]
13. Analysis of E6 variants of human papillomavirus type 33, 52 and 58 in Japanese women with cervical intraepithelial neoplasia/cervical cancer in relation to their oncogenic potential.
Xin CY; Matsumoto K; Yoshikawa H; Yasugi T; Onda T; Nakagawa S; Yamada M; Nozawa S; Sekiya S; Hirai Y; Shiromizu K; Fujii T; Taketani Y
Cancer Lett; 2001 Sep; 170(1):19-24. PubMed ID: 11448530
[TBL] [Abstract][Full Text] [Related]
14. Genetic variations of E6 and long control region of human papillomavirus type 16 from patients with cervical lesion in Liaoning, China.
Sun Z; Lu Z; Liu J; Wang G; Zhou W; Yang L; Liu C; Wang B; Ruan Q
BMC Cancer; 2013 Oct; 13():459. PubMed ID: 24099556
[TBL] [Abstract][Full Text] [Related]
15. Safety and immunogenicity of TA-HPV, a recombinant vaccinia virus expressing modified human papillomavirus (HPV)-16 and HPV-18 E6 and E7 genes, in women with progressive cervical cancer.
Kaufmann AM; Stern PL; Rankin EM; Sommer H; Nuessler V; Schneider A; Adams M; Onon TS; Bauknecht T; Wagner U; Kroon K; Hickling J; Boswell CM; Stacey SN; Kitchener HC; Gillard J; Wanders J; Roberts JS; Zwierzina H
Clin Cancer Res; 2002 Dec; 8(12):3676-85. PubMed ID: 12473576
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus type 16 E2 and E6/E7 variants.
Swan DC; Rajeevan M; Tortolero-Luna G; Follen M; Tucker RA; Unger ER
Gynecol Oncol; 2005 Mar; 96(3):695-700. PubMed ID: 15721413
[TBL] [Abstract][Full Text] [Related]
17. HPV16 E6 polymorphism and physical state of viral genome in relation to the risk of cervical cancer in women from the south of Poland.
Szostek S; Zawilinska B; Klimek M; Kosz-Vnenchak M
Acta Biochim Pol; 2017; 64(1):143-149. PubMed ID: 27801430
[TBL] [Abstract][Full Text] [Related]
18. Novel oligomannose liposome-DNA complex DNA vaccination efficiently evokes anti-HPV E6 and E7 CTL responses.
Mizuuchi M; Hirohashi Y; Torigoe T; Kuroda T; Yasuda K; Shimizu Y; Saito T; Sato N
Exp Mol Pathol; 2012 Feb; 92(1):185-90. PubMed ID: 22032938
[TBL] [Abstract][Full Text] [Related]
19. HPV16 E6 variants: frequency, association with HPV types and in silico analysis of the identified novel variants.
Gokhale PS; Sonawani A; Idicula-Thomas S; Kerkar S; Tongaonkar H; Mania-Pramanik J
J Med Virol; 2014 Jun; 86(6):968-74. PubMed ID: 24610458
[TBL] [Abstract][Full Text] [Related]
20. Circulating human papillomavirus type 16 specific T-cells are associated with HLA Class I expression on tumor cells, but not related to the amount of viral oncogene transcripts.
de Boer MA; Jordanova ES; van Poelgeest MI; van den Akker BE; van der Burg SH; Kenter GG; Fleuren GJ
Int J Cancer; 2007 Dec; 121(12):2711-5. PubMed ID: 17724722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
